Prostate cancer decisions — 2025

The Board denied the veteran's claims for increased ratings for prostate cancer, erectile dysfunction, and posttraumatic stress disorder.

The Veteran's residuals of prostate cancer were granted a 40 percent disability rating, and TDIU was granted based on the service-connected prostate cancer residuals.

The Board granted readjudication of the claim for service connection for prostate cancer based on new and relevant evidence, but remanded the matter to the RO for further development.

The Board remands the claims for an increased rating and earlier effective date for heart disability, increased rating for prostate cancer, special monthly compensation based on need for aid and attendance, and entitlement to TDIU due to inadequate VA examinations.

The Board remands the claims for an increased rating and earlier effective date for heart disability, increased rating for prostate cancer, special monthly compensation based on need for aid and attendance, and entitlement to TDIU due to inadequate VA examinations.

The Board denied service connection for asbestosis, diseased gallbladder, pancreatic attacks, and prostate cancer due to a lack of evidence supporting the claims.

The Board granted service connection for bilateral hearing loss and a disability rating of 10 percent for residuals of prostate cancer.

The Board remands the Veteran's claims for service connection for various conditions, including a psychiatric disability, sleep disorder, skin cancer residuals, prostate cancer residuals, chronic obstructive pulmonary disease (COPD), and dementia, due to insufficient evidence regarding his Vietnam or Thailand service.

The Board grants service connection for prostate cancer due to the Veteran's in-service exposure to contaminated water at Camp Lejeune.

The Board denied service connection for prostate cancer as there was no evidence of in-service incurrence or a link to service, and the Veteran's discharge from his second period of active service is dishonorable.

The appeal for an earlier effective date for the award of service connection for prostate cancer was denied.

The Board remands the claims for service connection due to a pre-decisional duty to assist error requiring further development of the Veteran's claim, including clarification of TERA exposures and obtaining an appropriate TERA examination.

The Board granted the restoration of a 20 percent rating for prostate cancer effective January 1, 2025, as the reduction was based on an inadequate VA examination and opinion.

The Board granted restoration of service connection for diabetes mellitus type II and prostate cancer, finding that the original grants were not clearly and unmistakably erroneous due to toxic exposure from the Veteran's military occupational specialty.

The Board granted service connection for prostate cancer residuals and remanded the claims for an acquired psychiatric disability, irritable bowel syndrome (IBS), chronic bronchitis, rhinitis, and sinusitis.

The Board remands the matter of entitlement to service connection for prostate cancer and residuals due to a pre-decisional duty to assist error, as the AOJ relied on an inadequate medical opinion.

The Board granted a total disability rating based on individual unemployability due to residuals of prostate cancer prostatectomy, resolving reasonable doubt in the Veteran's favor.

The Board remands the claims for service connection for a male genitourinary disability and erectile dysfunction due to an inadequate VA examination.

The Board remands the case to address the Veteran's claim of clear and unmistakable error in a prior rating decision regarding service connection for prostate cancer.

The Board remands the claims for an increased rating and earlier effective date for the Veteran's heart disability, an increased rating for prostate cancer, SMC based on the need for aid and attendance, and a TDIU due to inadequate VA examinations.